Low cardiac vagal tone index by heart rate variability differentiates bipolar from major depression

World Journal of Biological Psychiatry

Volumn 20, Issue 5, 2019, Pages 359-367

  Hage, Brandon ^a   Britton, Briana ^a   Daniels, David ^a   Heilman, Keri ^b   Porges, Stephen W ^b,c   Halaris, Angelos ^d  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c INDIANA UNIVERSITY   (United States)

^d LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

biochemical markers; Bipolar affective disorder; heart rate variability; major depressive disorder; respiratory sinus arrhythmia

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; BIOLOGICAL MARKER; C REACTIVE PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; MOOD STABILIZER; TUMOR NECROSIS FACTOR;

ADULT; ARTICLE; BIPOLAR DEPRESSION; CONTROLLED STUDY; FEMALE; HEART RATE VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PSYCHOPHARMACOTHERAPY; RESPIRATORY SINUS ARRHYTHMIA; VAGUS TONE; BIPOLAR DISORDER; BLOOD; COMPARATIVE STUDY; HEART; HEART RATE; MIDDLE AGED; PATHOPHYSIOLOGY; VAGUS NERVE;

ADULT; ANTIDEPRESSIVE AGENTS; BIOMARKERS; BIPOLAR DISORDER; DEPRESSIVE DISORDER, MAJOR; FEMALE; HEART; HEART RATE; HUMANS; MALE; MIDDLE AGED; VAGUS NERVE;

EID: 85030665554     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.1080/15622975.2017.1376113     Document Type: Article

References (41)

1. Bai Y, Su T, Li C, Tsai S, Chen M, Tu P, Chiou W., 2014. Comparison of pro-inflammatory cytokines among patients with bipolar disorder and unipolar depression and normal controls. Bipolar Disord. 7:269–277.
2. Baldessarini RJ, Faedda GL, Offidani E, Vázquez GH, Marangoni C, Serra G, Tondo L., 2013. Antidepressant-associated mood-switching and transition from unipolar major depression to bipolar disorder: a review. J Affect Disord. 148:129–135.
3. Barnes J, Mondelli V, Pariante CM., 2016. Genetic contributions of inflammation to depression. Neuropsychopharma-cology. 42:81–98.
4. Berry S, Broglio K, Bunker M, Jayewardene A, Olin B, Rush J., 2013. A patient-level meta-analysis of studies evaluating vagus nerve stimulation therapy for treatment-resistant depression. Med Devices (Auckl). 6:17–35.
5. CardioBatch software. 2007. Brain-Body Center, University of Illinois at Chicago.
6. CardioEdit software. 2007. Brain-Body Center, University of Illinois at Chicago.
7. Chang H, Chang C, Kuo T, Huang S., 2015. Distinguishing bipolar II depression from unipolar major depressive disorder: differences in heart rate variability. World J Biol Psychiatry. 16:351–360.
8. Chew M, Mulsant B, Pollock B, Lehman M, Greenspan A, Kirshner M, Bies R, Kapur S, Gharabawi G., 2006. A model of anticholinergic activity of atypical antipsychotic medications. Schizophr Res. 8:63–72.
9. Clancy J, Mary D, Witte K, Greenwood J, Deuchars S, Deuchars J., 2014. Non-invasive vagus nerve stimulation in healthy humans reduces sympathetic nerve activity. Brain Stimul. 7:871–877.
10. Eckberg D., 2000. Physiological basis for human autonomic rhythms. Ann Med. 32:341–349.
11. Etain B, Lajnef M, Bellivier F, Mathieu F, Raust A, Cochet B, Gard S, M’Bailara K, Kahn JP, Elgrabli O, et al. 2012. Clinical expression of bipolar disorder type I as a function of age and polarity at onset. J Clin Psychiatry. 73:561–566.
12. Ferrari AJ, Stockings E, Khoo JP, Erskine HE, Degenhardt L, Vos T, Whiteford HA., 2016. The prevalence and burden of bipolar disorder: findings from the global burden of disease study 2013. Bipolar Disord. 18:440–450.
13. Frasure-Smith N, Lespérance F, Irwin MR, Talajic M, Pollock BG., 2009. The relationships among heart rate variability, inflammatory markers and depression in coronary heart disease patients. Brain Behav Immun. 23:1140–1147.
14. Greenberg P, Fournier A, Sisitsky T, Pike C, Kessler R., 2015. The economic burden of adults with major depressive disorder in the United States (2005 and 2010). J Clin Psychiatry. 76:155–162.
15. Grippo A, Lamb D, Carter C, Porges S., 2007. Cardiac regulation in the socially monogamous prairie vole. Physiol Behav. 90:386–393.
16. Halaris A, Alvi N, Meresh E, Sharma A., 2014. Inflammation control reverses treatment-resistance in bipolar depression. Neurol Psychiatry Brain Res. 20:12–13.
17. Halaris A, Myint A-M, Savant V, Meresh E, Lim E, Guillemin G, Hoppensteadt D, Fareed J, Sinacore J., 2015. Does escitalopram reduce neurotoxicity in major depression? J Psychiatr Res. 66-67:118–126.
18. Heathers J., 2014. Everything hertz: methodological issues in short-term frequency-domain HRV. Front Physiol. 5:177.
19. Hirschfeld R., 2014. Differential diagnosis of bipolar disorder and major depressive disorder. J Affect Disord. 169:S12–S16.
20. Isomura S, Onitsuka T, Tsuchimoto R, Nakamura I, Hirano S, Oda Y, Oribe N, Hirano Y, Ueno T, Kanba S., 2016. Differentiation between major depressive disorder and bipolar disorder by auditory steady-state responses. J Affect Disord. 190:800–806.
21. Kamath M, Fallen E., 1996. Power spectral analysis of heart rate variability: a noninvasive signature of cardiac autonomic function. Crit Rev Biomed Eng. 21:245–311.
22. Lewis G, Furman S, McCool M, Porges S., 2012. Statistical strategies to quantify respiratory sinus arrhythmia: are commonly used metrics equivalent? Biological Psychol. 89:349–364.
23. Linder J, Sodhi S, Haynes W, Fiedorowicz J., 2014. Effects of antipsychotic drugs on cardiovascular variability in participants with bipolar disorder. Hum Psychopharmacol. 29:145–151.
24. Martin C, Tansey KE, Schalkwyk LC, Powell TR., 2015. The inflammatory cytokines: molecular biomarkers for major depressive disorder? Biomark Med. 9:169–180.
25. Muench J, Hamer A., 2010. Adverse effects of antipsychotic medications. Am Fam Physician. 81:617–622.
26. Munoz M, Van Roon A, Riese H, Thio C, Oostenbroek E, Westrik I, De Geus E, Gansevoort R, Lefrandt J, Nolte I, et al. 2015. Validity of (ultra-) short recordings for heart rate variability measurements. PLos One. 10:e0138921.
27. Pagani M, Lucini D, Porta A., 2012. Sympathovagal balance from heart rate variability: time for a second round? Exp Physiol. 97:1141–1142.
28. Pavlov V, Tracey K., 2009. The cholinergic anti-inflammatory pathway. Brain Behav Immun. 19:493–499.
29. Piletz J, Halaris A, Iqbal O, Hoppenstaedt D, Fareed J, Zhu H, Sinacore J, DeVane CL., 2009. Pro-inflammatory biomakers in depression: treatment with venlafaxine. World J Biol Psychiatry. 10:313–323.
30. Pizzi C, Manzoli L, Mancini S, Costa GM., 2009. Analysis of potential predictors of depression among coronary heart disease risk factors including heart rate variability, markers of inflammation, and endothelial function. Eur Heart J. 29:1110–1117.
31. Porges S., 2007. The polyvagal perspective. Biol Psychol. 74:116–143.
32. Porges S., Method and Apparatus for Evaluating Rhythmic Oscillations in Aperiodic Physiological Response Systems. 1985 April 16. Washington DC: U.S. Patent Office. Patent Number: 4,510,944.
33. Powell TR, Mcguffin P, D'souza UM, Cohen-Woods S, Hosang GM, Martin C, Schalkwyk LC., 2014. Putative transcriptomic biomarkers in the inflammatory cytokine pathway differentiate major depressive disorder patients from control subjects and bipolar disorder patients. PLoS One. 9:e91076.
34. Redlich R, Almeida JJ, Grotegerd D, Opel N, Kugel H, Heindel W, Arolt V, Phillips M, Dannlowski U., 2014. Brain morphometric biomarkers distinguishing unipolar and bipolar depression. A voxel-based morphometry-pattern classification approach. JAMA Psychiatry. 71:1222.
35. Reeves WC, Strine TW, Pratt LA, Thompson W, Ahluwalia I, Dhingra SS, McKnight-Eily LR, Harrison L, D'Angelo DV, Williams L, et al. 2011. Mental illness surveillance among adults in the United States. MMWR Suppl. 60(3):1–29.
36. Reyes del Paso G, Langewitz W, Mulder L, Roon A, Duschek S., 2013. The utility of low frequency heart rate variability as an index of sympathetic cardiac tone: a review with emphasis on a reanalysis of previous studies. Psychophysiology. 50:477–487.
37. Riniolo T, Porges S., 2000. Evaluating group distributional characteristics: why psychophysiologists should be interested in qualitative departures from the normal distribution. Psychophysiology. 37:21–28.
38. Sartorius N, Ustun T, Lecrubier Y, Wittchen H., 1996. Depression comorbid with anxiety: results from the WHO study on psychological disorders in primary health care. Br J Psychiatry Suppl. 168:38–43.
39. Serra G, Koukopoulos A, Chiara LD, Napoletano F, Koukopoulos AE, Curto M, Manfredi G, Faedda G, Girardi P, Baldessarini RJ., 2015. Features preceding diagnosis of bipolar versus major depressive disorders. J Affect Disord. 173:134–142.
40. Tarkiainen T, Timonen K, Tiittanen P, Hartikainen J, Pekkanen J, Hoek G, Ibald-Mulli A, Vanninen E., 2005. Stability over time of short-term heart rate variability. Clin Auton Res. 15:394–399.
41. Tracey K., 2007. Physiology and immunology of the cholinergic antiinflammatory pathway. J Clin Invest. 117:289–296.